Oulu

Finland

170 total trials 76 recruiting

Filter these 170 trials by phase, condition, sponsor and more.

Open in Search →

This is a phase III randomised, double-blind, placebo-controlled, multicentre, global study to assess the effectiveness and safety of standa … Ended

2022-502747-35-00 5 2019-02-18 Newly diagnosed advanced (FIGO stage III-IV) high grade epithelial ova
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3 … Ended

2022-501251-81-00 5 2017-06-08 Renal cell carcinoma

Showing 169–170 of 170 trials